Table 1.
Baseline | At 1 month | At 2 months | At 3 months | At 4 months | At 5 months | At 8 months | |
---|---|---|---|---|---|---|---|
Hb, mg/dL | 11.3 | 11.2 | 11.6 | 13 | 12.4 | 12.3 | 11 |
Ferritin, ng/mL | 111 | 146 | 468 | 372 | 437 | ||
Tsat, % | 25 | 21 | 38 | 33 | 41 | ||
Serum creatinine, mg/dL | 6.58 | 7.2 | 8.03 | 8.24 | 7.49 | 9.63 | 8.9 |
Serum urea, mg/dL | 168 | 190 | 212 | 191 | 159 | 195 | 169 |
Kur, mL/min | 5 | 4.8 | 4.73 | 4.65 | 4.7 | 4.6 | 4.65 |
Residual diuresis, mL/24 h | 1,550 | 1,800 | 1,900 | 1,800 | 1,800 | 1,800 | 1,900 |
CrCl, mL/min | 7.6 | 5.89 | 6 | 5.3 | 5.5 | 5.4 | 5.5 |
UACR, mg/g | 733.69 | 579.52 | 731 | 655 | 556 | 289.47 | |
Ca, mg/dL | 8.5 | 9.1 | 9.1 | 8.5 | 9.5 | 8.3 | 8.1 |
Phos, mg/dL | 5.1 | 4.8 | 4.7 | 5.6 | 6.2 | 4.5 | 3.8 |
Serum albumin, mg/dL | 3.89 | 3.9 | 4.14 | 4.08 | 4.25 | 3.87 | 3.87 |
PTH, pg/mL | 555 | 821 | 600.6 | 600 | 722 | 465 | |
Calcitriol, ng/mL | 8.59 | 17.59 | 13.72 | 15 | 9.34 | ||
Mg, mg/dL | 2.27 | 2.3 | 2.20 | 2.48 | 2.33 | 2.23 | 2.26 |
Na, mmol/L | 140 | 140 | 137 | 136 | 139 | 136 | 136 |
Serum K, mmol/L | 5.9 | 6.5 | 7.1 | 6.5 | 6.5 | 4.7 | 4.9 |
Serum bicarbonate, mmol/L | 17.9 | 19.4 | 17.9 | 18.2 | 18.5 | 23 | 23.6 |
HDF, L | 20 | 23 | 26.4 | 26 | 29.4 | 26.9 | |
KT, L | 53 | 57 | 56.7 | 56.18 | 55 | 53.4 | |
IDWG, kg | 0.7 | 0.87 | 1 | 0.62 | 0.53 | 0.52 | |
ESA, U/wk | 3,000 | 5,000 | 3,000 | 2,000 | 2,000 | 4,000 | |
Treatment hyperkalemia | CPS (3 Env/wk) | CPS (3 Env/wk) | CPS (4 Env/wk) | CPS (1 Env/d) | CPS (2 Env/d) | Patiromer | Patiromer |
Hb, hemoglobin; Tsat, transferrin saturation; Kru, residual kidney urea clearance; CrCl, creatinine clearance in 24h; Ca, serum calcium; Mg, serum magnesium; Phos, serum phosphorus; PTH, parathyroid hormone; Calcitriol, 1,25-(OH)2 vitamin D3; IDWG, interdialytic weight gain; ESA, erythropoietin stimulating agent; CPS, calcium polystyrene sulfonate; UACR, urine albumin-to-creatinine ratio; Env, envolved.